MedPath

TANTA UNIVERSITY

TANTA UNIVERSITY logo
🇪🇬Egypt
Ownership
Private
Established
1972-01-01
Employees
1K
Market Cap
-
Website
http://www.tanta.edu.eg

Isotretinoin in Treatment of COVID-19

Phase 3
Conditions
COVID-19
Interventions
First Posted Date
2020-04-24
Last Posted Date
2020-09-23
Lead Sponsor
Tanta University
Target Recruit Count
300
Registration Number
NCT04361422

Hydroxychloroquine and Nitazoxanide Combination Therapy for COVID-19

Phase 2
Conditions
COVID-19
Interventions
Other: Standard care
Combination Product: Hydroxychloroquine plus Nitazoxanide
First Posted Date
2020-04-24
Last Posted Date
2020-04-24
Lead Sponsor
Tanta University
Target Recruit Count
100
Registration Number
NCT04361318

Efficacay of Chloroquine or Hydroxychloroquine in COVID-19 Treatment

Phase 2
Completed
Conditions
Coronavirus Infection
COVID-19
Interventions
First Posted Date
2020-04-20
Last Posted Date
2021-08-02
Lead Sponsor
Tanta University
Target Recruit Count
194
Registration Number
NCT04353336
Locations
🇪🇬

Tanta University, Assiut University, Tanta, Egypt

Efficacy of Faviprevir in COVID-19 Treatment

Phase 2
Completed
Conditions
COVID
Interventions
First Posted Date
2020-04-17
Last Posted Date
2021-11-01
Lead Sponsor
Tanta University
Target Recruit Count
92
Registration Number
NCT04351295
Locations
🇪🇬

Tanta University, Ainshams University, Tanta, Egypt

The Efficacy of Ivermectin in Larger Doses in COVID-19 Treatment

Phase 2
Recruiting
Conditions
COVID
Interventions
First Posted Date
2020-04-17
Last Posted Date
2021-03-10
Lead Sponsor
Tanta University
Target Recruit Count
300
Registration Number
NCT04351347
Locations
🇪🇬

Tanta University, Tanta, Egypt

Angiotensin Converting Enzyme Inhibitors in Treatment of Covid 19

Phase 3
Not yet recruiting
Conditions
COVID
Interventions
Drug: ACEIs
Drug: Conventional treatment
First Posted Date
2020-04-14
Last Posted Date
2020-04-14
Lead Sponsor
Tanta University
Target Recruit Count
60
Registration Number
NCT04345406
Locations
🇪🇬

Tanta University, Tanta, Egypt

Remdesivir Efficacy in Coronavirus Disease

Phase 2
Completed
Conditions
COVID
Interventions
Other: Standard of care treatment
First Posted Date
2020-04-14
Last Posted Date
2021-08-02
Lead Sponsor
Tanta University
Target Recruit Count
200
Registration Number
NCT04345419
Locations
🇪🇬

Tanta university hospital, Assuit University, Ainshams University, Tanta, Egypt

Effect of Ultra-short-term Treatment of Patients With Iron Deficiency or Anemia Undergoing Adolescent Scoliosis Correction

Not Applicable
Completed
Conditions
Ultra-short-term
Iron Deficiency Anemia
Scoliosis Idiopathic
Interventions
Drug: Placebo
Drug: ferric carboxymaltose , α erythropoietin, vitamin B12, oral folic acid
First Posted Date
2020-04-13
Last Posted Date
2025-04-16
Lead Sponsor
Tanta University
Target Recruit Count
44
Registration Number
NCT04343170
Locations
🇪🇬

tarek Abdel Lattif, Tanta, Egypt

Pecto-intercostal Plane Block in On-pump Coronary Bypass Graft Surgery

Not Applicable
Completed
Conditions
Enhanced Recovery After Cardiac Surgery
Interventions
Procedure: pecto-intercostal plane block
First Posted Date
2020-04-13
Last Posted Date
2022-08-10
Lead Sponsor
Tanta University
Target Recruit Count
40
Registration Number
NCT04343105
Locations
🇪🇬

Tarek Abdel Hay, Tanta, El Gharbyia, Egypt

Ultrasound Guided Bilateral Erector Spinae Block as Analgesia for Adolescent Idiopathic Scoliosis Correction

Not Applicable
Suspended
Conditions
Erector Spinae Block
Analgesia
Scoliosis Idiopathic
Interventions
Procedure: sham bilateral ultrasounded guided erector spinae block
Procedure: erector spinae block
Drug: normal saline
First Posted Date
2020-04-07
Last Posted Date
2025-04-16
Lead Sponsor
Tanta University
Target Recruit Count
40
Registration Number
NCT04336046
Locations
🇪🇬

tarek Abdel Lattif, Tanta, Egypt

© Copyright 2025. All Rights Reserved by MedPath